Provided by Tiger Trade Technology Pte. Ltd.

Skye Bioscience Inc.

1.78
-0.1750-8.97%
Pre-market: 1.960.1850+10.42%05:24 EDT
Volume:78.29K
Turnover:144.96K
Market Cap:7.79M
PE:-0.17
High:1.95
Open:1.95
Low:1.76
Close:1.95
52wk High:39.92
52wk Low:1.76
Shares:4.39M
Float Shares:2.87M
Volume Ratio:0.76
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.2399
EPS(LYR):-11.2801
ROE:-233.87%
ROA:-95.06%
PB:-15.67
PE(LYR):-0.16

Loading ...

Oct 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 03, 2024

Major Issues Report

Form 8-K - Current report
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Correspondence

Form CORRESP - Correspondence
May 16, 2024

Correspondence

Form CORRESP - Correspondence
May 15, 2024

Correspondence

Form CORRESP - Correspondence
May 15, 2024

Correspondence

Form CORRESP - Correspondence
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 10, 2024

Correspondence

Form CORRESP - Correspondence
Apr 10, 2024

Correspondence

Form CORRESP - Correspondence
Apr 10, 2024

Correspondence

Form CORRESP - Correspondence
Apr 04, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 03, 2024

Major Issues Report

Form 8-K - Current report
Mar 27, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]